Clean Yield Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.16M | Sell |
26,322
-359
| -1% | -$69.8K | 1.45% | 18 |
|
|
2025
Q4 | $4.63M | Buy |
26,681
+24
| +0.1% | +$4.37K | 1.29% | 25 |
|
|
2025
Q3 | $5.08M | Buy |
26,657
+111
| +0.4% | +$19.7K | 1.44% | 23 |
|
|
2025
Q2 | $4.77M | Sell |
26,546
-1,078
| -4% | -$187K | 1.43% | 24 |
|
|
2025
Q1 | $4.67M | Buy |
27,624
+1,196
| +5% | +$196K | 1.52% | 20 |
|
|
2024
Q4 | $3.99M | Buy |
26,428
+3,983
| +18% | +$619K | 1.27% | 25 |
|
|
2024
Q3 | $3.48M | Buy |
22,445
+3,325
| +17% | +$497K | 1.1% | 32 |
|
|
2024
Q2 | $2.62M | Buy |
19,120
+11
| +0.1% | +$1.51K | 0.98% | 33 |
|
|
2024
Q1 | $2.54M | Buy |
19,109
+3,308
| +21% | +$429K | 0.99% | 33 |
|
|
2023
Q4 | $2.18M | Buy |
15,801
+475
| +3% | +$62.4K | 0.92% | 37 |
|
|
2023
Q3 | $1.88M | Sell |
15,326
-50
| -0.3% | -$6.66K | 0.83% | 38 |
|
|
2023
Q2 | $2.16M | Sell |
15,376
-95
| -0.6% | -$13.1K | 0.89% | 33 |
|
|
2023
Q1 | $2.19M | Buy |
15,471
+149
| +1% | +$21.3K | 0.93% | 33 |
|
|
2022
Q4 | $2.4M | Buy |
15,322
+77
| +0.5% | +$11.1K | 1.03% | 31 |
|
|
2022
Q3 | $1.87M | Buy |
15,245
+327
| +2% | +$43.1K | 0.87% | 37 |
|
|
2022
Q2 | $1.98M | Sell |
14,918
-1,383
| -8% | -$188K | 0.82% | 36 |
|
|
2022
Q1 | $2.23M | Sell |
16,301
-985
| -6% | -$137K | 0.79% | 40 |
|
|
2021
Q4 | $2.99M | Sell |
17,286
-1,383
| -7% | -$210K | 0.96% | 35 |
|
|
2021
Q3 | $2.71M | Sell |
18,669
-2,362
| -11% | -$346K | 0.89% | 34 |
|
|
2021
Q2 | $2.78M | Sell |
21,031
-1,105
| -5% | -$145K | 0.94% | 34 |
|
|
2021
Q1 | $2.84M | Buy |
22,136
+244
| +1% | +$30.1K | 1.07% | 32 |
|
|
2020
Q4 | $2.61M | Sell |
21,892
-135
| -0.6% | -$16.5K | 0.94% | 33 |
|
|
2020
Q3 | $2.52M | Sell |
22,027
-207
| -0.9% | -$24.5K | 1.02% | 24 |
|
|
2020
Q2 | $2.53M | Sell |
22,234
-855
| -4% | -$90.7K | 1.1% | 27 |
|
|
2020
Q1 | $1.85M | Buy |
23,089
+18,244
| +377% | +$1.89M | 0.88% | 33 |
|
|
2019
Q4 | $517K | Sell |
4,845
-600
| -11% | -$62.6K | 0.16% | 86 |
|
|
2019
Q3 | $583K | Hold |
5,445
| – | – | 0.19% | 80 |
|
|
2019
Q2 | $554K | Buy |
5,445
+20
| +0.4% | +$1.92K | 0.2% | 77 |
|
|
2019
Q1 | $488K | Sell |
5,425
-90
| -2% | -$7.8K | 0.2% | 84 |
|
|
2018
Q4 | $459K | Sell |
5,515
-460
| -8% | -$43.1K | 0.2% | 89 |
|
|
2018
Q3 | $645K | Sell |
5,975
-465
| -7% | -$51K | 0.26% | 79 |
|
|
2018
Q2 | $707K | Buy |
6,440
+255
| +4% | +$26.6K | 0.29% | 77 |
|
|
2018
Q1 | $620K | Sell |
6,185
-275
| -4% | -$28.2K | 0.26% | 81 |
|
|
2017
Q4 | $636K | Buy |
6,460
+185
| +3% | +$17.5K | 0.25% | 83 |
|
|
2017
Q3 | $588K | Sell |
6,275
-160
| -2% | -$17K | 0.24% | 85 |
|
|
2017
Q2 | $702K | Sell |
6,435
-100
| -2% | -$10.6K | 0.29% | 78 |
|
|
2017
Q1 | $642K | Hold |
6,535
| – | – | 0.27% | 80 |
|
|
2016
Q4 | $601K | Hold |
6,535
| – | – | 0.27% | 81 |
|
|
2016
Q3 | $553K | Sell |
6,535
-65
| -1% | -$5.46K | 0.24% | 84 |
|
|
2016
Q2 | $537K | Buy |
+6,600
| New | +$503K | 0.23% | 87 |
|
Other funds holding DGX
VCM
VPM
EIG
Clean Yield Group's DGX Position: Q1 2026 in Review
Clean Yield Group reduced its Quest Diagnostics (DGX) stake by 1.3% in Q1 2026, selling an estimated $69.8K and leaving 26,322 shares worth $5.16M. The position accounts for 1.45% of the portfolio, ranked #18.
Clean Yield Group first reported a position in DGX in Q2 2016 and has held it in 40 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Clean Yield Group held 26,322 shares of Quest Diagnostics worth $5.16M as of Q1 2026.
- Clean Yield Group sold 359 Quest Diagnostics shares in Q1 2026, an estimated $69.8K.
- Quest Diagnostics made up 1.45% of Clean Yield Group's portfolio in Q1 2026, its #18 holding.
- Clean Yield Group first reported a position in Quest Diagnostics in Q2 2016 and has held it in 40 quarters since.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.